Published in Acta Med Scand on January 01, 1978
Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS | NCT00467610
Panhematin provides a therapeutic benefit in experimental pancreatitis. Gut (2010) 2.23
Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation. Proc Natl Acad Sci U S A (1981) 2.04
The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am J Pathol (2000) 1.77
Carbon monoxide reverses diabetic gastroparesis in NOD mice. Am J Physiol Gastrointest Liver Physiol (2010) 1.11
Liver transplantation in the management of porphyria. Hepatology (2014) 0.97
Liver Transplantation because of Acute Liver Failure due to Heme Arginate Overdose in a Patient with Acute Intermittent Porphyria. Case Rep Gastroenterol (2012) 0.88
Hematin-derived anticoagulant. Generation in vitro and in vivo. J Exp Med (1986) 0.87
Systemic hemin therapy attenuates blood-brain barrier disruption after intracerebral hemorrhage. Neurobiol Dis (2014) 0.87
Renal failure affects the enzymatic activities of the three first steps in hepatic heme biosynthesis in the acute intermittent porphyria mouse. PLoS One (2012) 0.84
Pharmacokinetics of intravenously administered haem arginate. Br J Clin Pharmacol (1986) 0.83
Acute Hepatic Porphyria. J Clin Transl Hepatol (2015) 0.80
Differential effects of metalloporphyrins on messenger RNA levels of delta-aminolevulinate synthase and heme oxygenase. Studies in cultured chick embryo liver cells. J Clin Invest (1994) 0.76
Incorporation of haemoglobin haem into the rat hepatic haemoproteins tryptophan pyrrolase and cytochrome P-450. Biochem J (1986) 0.75
Plasma heme-induced renal toxicity is related to a capillary rarefaction. Sci Rep (2017) 0.75
Heme Oxygenase 1 as a Therapeutic Target in Acute Kidney Injury. Am J Kidney Dis (2017) 0.75
Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature (1989) 5.10
Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev (1999) 2.91
How well are complete dentures copied? Br Dent J (1998) 2.58
B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell (1987) 2.44
Tongue control of upper complete dentures: a clinical hint. Br Dent J (1991) 1.94
Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J Immunol (2001) 1.93
Sildenafil (Viagra) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current. Circulation (2000) 1.91
Capillary LC-MS2 at the attomole level for monitoring and discovering endogenous peptides in microdialysis samples collected in vivo. Anal Chem (2001) 1.71
Stat5 as a target for regulation by extracellular matrix. J Biol Chem (1995) 1.61
Identification of isomers differing from 9, alpha, in the early labelled bilirubin of the bile. Proc Soc Exp Biol Med (1966) 1.54
Quantitative Differentiation of Minute Amounts of the Coproporphyrin Isomers (I and III) Based on Fluorescence Behavior. Science (1946) 1.50
Cycle length dynamics at the onset of postinfarction ventricular tachycardias induced in canines: dependence on interval-dependent excitation properties of the reentrant substrate. J Cardiovasc Electrophysiol (2000) 1.48
The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals. J Lab Clin Med (1971) 1.47
Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci (Lond) (1998) 1.46
THE CONVERSION OF HEMATIN TO BILIRUBIN FOLLOWING INTRAVENOUS ADMINISTRATION IN HUMAN SUBJECTS. J Clin Invest (1945) 1.46
Porphyria variegata and porphyria cutanea tarda in siblings: chemical and genetic aspects. Proc Natl Acad Sci U S A (1975) 1.43
Onset of manifestations of hepatic porphyria in relation to the influence of female sex hormones. Arch Intern Med (1966) 1.43
Radioimmunoassay of mammalian type-C polypeptides. IV. Characterization of woolly monkey and gibbon viral antigens. Int J Cancer (1973) 1.42
A safe simple method for removal of the gallbladder through the umbilical trocar site during laparoscopic surgery. J Laparoendosc Surg (1994) 1.39
Potential dangers of laparoscopic insufflator. Lancet (1992) 1.39
Successful use of size-mismatched liver allografts in children by delayed primary closure of the abdominal wall. Br J Surg (1996) 1.39
A survey of complete denture prosthetics for the elderly, the handicapped and difficult patients. Br Dent J (1992) 1.37
The role of Stat3 in apoptosis and mammary gland involution. Conditional deletion of Stat3. Adv Exp Med Biol (2000) 1.34
Inhibition of folate enzymes by sulfasalazine. J Clin Invest (1978) 1.34
Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation (2000) 1.33
Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin. Proc Natl Acad Sci U S A (1971) 1.33
Efficient BLG-Cre mediated gene deletion in the mammary gland. Transgenic Res (1998) 1.33
The clinical porphyrias. Semin Hematol (1968) 1.28
NF-kappaB inhibits apoptosis in murine mammary epithelia. J Biol Chem (2000) 1.25
Epicardial and endocardial mapping of ventricular tachycardia in patients with myocardial infarction. Is the origin of the tachycardia always subendocardially localized? Circulation (1991) 1.25
Regulation of the sheep beta-lactoglobulin gene by lactogenic hormones is mediated by a transcription factor that binds an interferon-gamma activation site-related element. Mol Endocrinol (1994) 1.24
Effect of hematin in acute porphyric relapse. Ann Intern Med (1973) 1.19
Differential activation of STATs 3 and 5 during mammary gland development. FEBS Lett (1996) 1.17
Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid. Clin Exp Immunol (2000) 1.16
Transient inhibition of interleukin 4 signaling by T cell receptor ligation. J Exp Med (2000) 1.16
Effects of hematin in hepatic porphyria. Further studies. Ann Intern Med (1975) 1.14
Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid. Clin Exp Immunol (1999) 1.14
DNA chip technology. J Pathol (1999) 1.13
Identification and characterisation of a developmentally regulated mammalian gene that utilises -1 programmed ribosomal frameshifting. Nucleic Acids Res (2001) 1.12
Activated human neutrophils express vascular endothelial growth factor (VEGF). Cytokine (1998) 1.10
Characterization of a nucleoside/proton symporter in procyclic Trypanosoma brucei brucei. J Biol Chem (1998) 1.08
Use of hematin in the acute attack of the "inducible" hepatic prophyrias. Adv Intern Med (1978) 1.07
The structure and expression of the preproenkephalin gene. Nucleic Acids Res (1982) 1.06
Differential regulation of nucleoside and nucleobase transporters in Crithidia fasciculata and Trypanosoma brucei brucei. Mol Biochem Parasitol (2000) 1.05
Apoptosis: the germs of death. Nat Cell Biol (1999) 1.05
Collagen-hyaluronic acid scaffolds for adipose tissue engineering. Acta Biomater (2010) 1.04
Cardiac responses to electrical stimulation of discrete loci in canine atrial and ventricular ganglionated plexi. Am J Physiol (1990) 1.04
Separation of bile pigments by thin layer chromatography. J Chromatogr (1968) 1.03
The mammary factor MPBF is a prolactin-induced transcriptional regulator which binds to STAT factor recognition sites. FEBS Lett (1994) 1.02
A new method of interpretation of the ferric chloride oxidation patterns of the urobilinoids. Arch Biochem Biophys (1969) 1.02
A novel cell culture model for studying differentiation and apoptosis in the mouse mammary gland. Breast Cancer Res (2000) 1.01
Mass spectrometry and ferric chloride oxidation applied to urobilinoid structures. Arch Biochem Biophys (1969) 1.01
A novel role for IRF-1 as a suppressor of apoptosis. Oncogene (2000) 1.00
Posttransplant problems requiring regrafting: an analysis of 72 patients with 96 liver retransplants. Transplant Proc (1995) 0.98
The isolation of crystalline i-urobilinogen (mesobilirubinogen) from feces. Comparison with crystalline d-urobilinogen (H44) and seprartion of natural i-urobilin into optically active components. J Biol Chem (1966) 0.98
Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10. J Immunol (1996) 0.96
Transcripts from an aberrantly re-arranged human T-cell receptor beta-chain gene. EMBO J (1985) 0.96
Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients. Br J Surg (2001) 0.96
p53-dependent apoptosis induced by proteasome inhibition in mammary epithelial cells. Cell Death Differ (2001) 0.95
Isolation of porphyrins from porphyria urine by preparative thin-layer chromatography. J Chromatogr (1968) 0.95
Stability of delta-aminolevulinic acid and porphobilinogen in urine under varying conditions. Clin Chem (1968) 0.95
NF-kappaB and apoptosis in mammary epithelial cells. J Mammary Gland Biol Neoplasia (1999) 0.95
The heart reinnervates after transplantation. Ann Thorac Surg (2000) 0.95
Uroporphyrinogen I synthase from human erythrocytes: separation, purification, and properties of isoenzymes. Proc Natl Acad Sci U S A (1979) 0.94
Randomized, prospective trial of cimetidine and ranitidine for control of intragastric pH in the critically ill. Surgery (1985) 0.94
Letter: Phialophora mutabilis endocarditis. Ann Intern Med (1973) 0.94
Biomimetic collagen scaffolds with anisotropic pore architecture. Acta Biomater (2011) 0.94
Negative inotropic and chronotropic effects of oxytocin. Hypertension (2001) 0.93
Postulated deficiency of hepatic heme and repair by hematin infusions in the "inducible" hepatic porphyrias. Proc Natl Acad Sci U S A (1977) 0.93
On the existence and structure of a new urobilin of molecular weight 592. Proc Natl Acad Sci U S A (1967) 0.92
The rate of intravenous cocaine administration alters c-fos mRNA expression and the temporal dynamics of dopamine, but not glutamate, overflow in the striatum. Brain Res (2008) 0.91
Enterohepatic circulation and conversion of protoporphyrin to bile pigment in man. Proc Soc Exp Biol Med (1968) 0.91
Cis-urocanic acid synergizes with histamine for increased PGE2 production by human keratinocytes: link to indomethacin-inhibitable UVB-induced immunosuppression. Photochem Photobiol (1995) 0.91